Page 101 - Tata_Chemicals_yearly-reports-2020-2021
P. 101

Integrated Report   Statutory Reports  Financial Statements
              1-59                Management Discussion and Analysis  147-300


            7.  Financial Performance
            (a)   Standalone performance for the year ended March 31, 2021
                                                                                                       ` in crore
                                          FY      FY              %
             Particulars                              Change          Remarks
                                      2020-21 2019-20         Change
             Revenue from operations    2,999   2,920     79       3  Basic Chemistry Products:
                                                                      Lower volumes of soda ash and lower realisation was
                                                                      compensated by higher volumes of salt. Revenue
                                                                      from sale of new cement variant contributed to higher
                                                                      revenue for the Company.
                                                                      Specialty Products:
                                                                      Due  to  increase  in  volume  of  products  related  to
                                                                      Nutrition Sciences and Silica.
             Other income                219     309     (90)    (29)  Other income has decreased mainly on account of
                                                                      lower interest on investments and lower dividend
                                                                      income from non-current investments.

             Cost of materials consumed  600     542      58      11  Cost of materials is higher due to higher input costs of
                                                                      raw materials and higher salt volumes.
             Purchases of stock-in-trade  153     94      59      63  Purchases  of  stock-in-trade  increased  mainly  on
                                                                      account of higher demand for Basic Chemistry
                                                                      Products and Nutrition Science related business.
             Power & fuel                489     555     (66)    (12)  The decrease in power and fuel cost is mainly on
                                                                      account of decrease in price of coal and other variants.
             Employee benefit expenses   250     250       -       -  Employee costs have remained constant and no change
                                                                      compared to FY 2019-20.
             Freight and forwarding charges  423  390     33       8  Freight and forwarding charges have increased majorly
                                                                      due to higher sales volumes of salt, nutrition business
                                                                      and silica products.
             Finance cost                 19      43     (24)    (56)  Finance costs decreased due to repayment of External
                                                                      Commercial Borrowings (ECB) and Non-Convertible
                                                                      Debentures (NCD) in FY 2019-20.

            (b)  Standalone Balance Sheet Analysis
            i.  Investments                                                                            ` in crore
                                                                                    FY      FY              %
             Particulars                                                                        Change
                                                                               2020-21 2019-20          Change
             Investments in equity instruments in subsidiaries                    3,606   3,606      -       -
             Investment in joint venture                                           336     336       -       -
             Investment in preference shares in subsidiaries                       815     815       -       -
             Investment in other companies                                        3,147   1,904   1,243     65
             Investments in NCDs                                                   150       -     150     100
             Investment in mutual funds                                           1,282   1,301    (19)     (1)
             Total                                                               9,336   7,962   1,374      17

            Increase in the value of investments in other companies is mainly due to changes in fair value of investments.


                                                                                                            99
   96   97   98   99   100   101   102   103   104   105   106